Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accounts Payables (2022 - 2025)

Historic Accounts Payables for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $2.3 million.

  • Lucid Diagnostics' Accounts Payables rose 1350.95% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 1350.95%. This contributed to the annual value of $2.8 million for FY2024, which is 2634.73% down from last year.
  • As of Q3 2025, Lucid Diagnostics' Accounts Payables stood at $2.3 million, which was up 1350.95% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Accounts Payables registered a high of $4.5 million during Q1 2022, and its lowest value of $1.1 million during Q3 2022.
  • Moreover, its 4-year median value for Accounts Payables was $2.4 million (2025), whereas its average is $2.6 million.
  • Within the past 5 years, the most significant YoY rise in Lucid Diagnostics' Accounts Payables was 19485.82% (2023), while the steepest drop was 5091.89% (2023).
  • Lucid Diagnostics' Accounts Payables (Quarter) stood at $1.4 million in 2022, then soared by 165.45% to $3.8 million in 2023, then dropped by 26.35% to $2.8 million in 2024, then dropped by 19.51% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $2.4 million for Q2 2025, and $2.1 million during Q1 2025.